Bicara Therapeutics Inc. (BCAX) Reports Q2 Loss of $0.82
Get Alerts BCAX Hot Sheet
Join SI Premium – FREE
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported Q2 EPS of ($0.82).
For earnings history and earnings-related data on Bicara Therapeutics Inc. (BCAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Ophir Metals names Eric Tsung as new CFO
- Li Auto reports 37,679 vehicle deliveries in August 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share